Robert Williams
Family Medicine · Ventura, CANPI 1245400951
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Biohorizons Implant Systems Inc. accounts for 62.8% of it on its own, with 3 other manufacturers making up the rest. That places this record below the midpoint for family medicine clinicians in CA, where the typical reported total is $232.
Across 6 payments — averaging $37.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohorizons Implant Systems Inc.$142
- Sanofi$36
- Teva Pharmaceuticals USA, Inc.$35
- Therapeuticsmd, Inc.$12
Across 461 payments — averaging $3293.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$763K
- Vertex$216K
- Nielsen Biosciences, Inc.$165K
- Currax Pharmaceuticals LLC$140K
- AstraZeneca$137K
- Sanofi US Services Inc.$38K
- plus $59K from 4 others
What the payments were for
- Food & beverage$227100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohorizons Implant Systems Inc. | 2 | $142 |
| Sanofi | 1 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Therapeuticsmd, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$227 in reported general payments places this provider in the 45th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 13 | $10,181 |
| XareltoRivaroxaban | 21 | $5,982 |
| EliquisApixaban | 17 | $4,897 |
| Clozapine | 18 | $1,542 |
| Ursodiol | 12 | $1,190 |
| Tamsulosin Hcl | 38 | $1,063 |
| Levetiracetam | 45 | $950 |
| Atorvastatin Calcium | 59 | $907 |
| Potassium Chloride | 25 | $814 |
| Baclofen | 36 | $771 |
| Gabapentin | 38 | $665 |
| Olanzapine | 16 | $652 |
| Sertraline Hcl | 24 | $641 |
| Duloxetine Hcl | 17 | $583 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 20 | $528 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Ventura
- John PrichardVentura$101K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.